The gender dimorphism of SLE is usually attributed to the fact that alterations in the immune-neuroendocrine system contribute to the development of autoimmunity, and therefore it is suggested that hormones, such as prolactin (PRL), modulate the immune response influencing the development of SLE (9, 10). This evidence concerns the gene PRL and systemic lupus erythematosus.